Evidence map›Paper›PMID 42187541›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2026

Brief Report: Sustainability of the Effects of Linkage Case Management on Posthospitalization HIV Outcomes: The Daraja Randomized Clinical Trial.

Megan Willkens, Benson Issarow, Godfrey A Kisigo, Severin Kabakama, Elialilia Okello, Thomas Rutachunzibwa, Derick Deogratias, Daniel W Fitzgerald, Philip Ayieko, Myung Hee Lee and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Megan WillkensCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY.ORCID 0009-0003-8184-1302
Benson IssarowMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Godfrey A KisigoMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Severin KabakamaMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Elialilia OkelloMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Thomas RutachunzibwaTanzanian Ministry of Health, Mwanza, Tanzania.
Derick DeogratiasMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Daniel W FitzgeraldCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY.
Philip AyiekoMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Myung Hee LeeCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY.
Lisa R MetschDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY.
Saidi KapigaMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Robert N PeckCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY.ORCID 0000-0002-4526-2480

Funding

Reducing Post-Hospital Mortality in HIV-Infected Adults in TanzaniaR01MH118107 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI PECK, ROBERT N · 2018 to 2022
$2.7M
Post-Doctoral Fellowship Training in HIV Clinical InvestigationD43TW011826 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI Daniel W Fitzgerald, Saidi Kapiga · 2021 to 2026
$1.9M
Patient-Oriented Research in Global Cardiovascular Diseases and Interactions with HIVK24HL170902 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Robert N Peck · 2023 to 2026
$504k
FIC NIH HHS D43 TW011826FIC NIH HHS D43TW011826NHLBI NIH HHS K24 HL170902NIMH NIH HHS R01 MH118107NIMH NIH HHS R01MH118107
6 · The paper itself

Abstract

introductionIn this prespecified analysis of a clinical trial to assess the effect of linkage case management on posthospital outcomes in people with HIV, we sought to evaluate the sustainability of the intervention effects from 12 to 24 months.

methodsParticipants in the Daraja trial were followed 12 months beyond the primary end point of 12 months to assess the sustainability of HIV outcomes 24 months after hospital discharge. Study outcomes were continuity in HIV care, persistent ART adherence, and sustained viral load suppression through 24 months, achieved at both 12-month and 24-month time points.

resultsFindings from 12 months after Daraja intervention completion indicate the sustainable effects of linkage case-management in people with HIV who had been hospitalized at the time the intervention was initiated. Intervention participants achieved higher rates of continuity in HIV care (78.6% vs 66.3%, P = 0.008), persistent ART adherence (74.1% vs 61.0%, P = 0.006), and persistent HIV viral load suppression (70.1% vs 57.6%, P = 0.01) compared with the standard of care sustained from through 24 months. The intervention effect on time to HIV clinic linkage and ART initiation also remained significant at 2 years with >10% of control participants remaining untreated after 2 years.

conclusionsThe Daraja intervention had a sustained effect on retention in HIV care, ART adherence, and viral load suppression among hospitalized people with HIV.

Indexed as

Anti-HIV AgentsCase ManagementContinuity of Patient CareHIV InfectionsAdherence InterventionsAdultFemaleHospitalizationHumansMaleMedication AdherenceMiddle AgedTreatment OutcomeViral LoadAnti-HIV Agentslinkage case managementpeople with HIVposthospitalization

Identifiers

PMID42187541
PMCPMC13532557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.